Skip to content

SINCLAIR PHARMACEUTICALS LTD

Active Risk: not assessed Foreign entityfounded 2011active for 15 yearsEDEN HOUSE-LAKESIDE-CHESTER BUS 0, CH4 9QT CHESTER, United KingdomKBO/BCE: BE 0834.487.832

Board

1 director, no change since 2025
Director
appointed by deed of 16-04-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“"L'administrateur unique notifie les changements intervenus au sein du conseil d'administration de la Société, à savoir la nomination de…”
deed of 16-04-2026

Office holders in the KBO →

Mandates through the years

4 names, the dashed line is today

Director

Director

Director

Director
BoardEarliermandate already running before its first mention
Mandates as a list
    • Director, appointed by deed of 16-04-2026, still in office
    • Director, appointed by deed of 16-04-2026, until 30-12-2025
    • Director, until 28-10-2025
    • Director, until 27-10-2025

Control

Articles of association

deed of 03-02-2020 (in French)
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
“Refuser d'inscrire la cession de toute Action”

Next steps